Browse > Article

A case of Graves' disease associated with myasthenia gravis and complicated with moyamoya disease  

Back, Ji-Hoon (Department of Internal Medcine, Presbyterian Medical Center)
Kang, Hye-Mi (Department of Internal Medcine, Presbyterian Medical Center)
Min, Byeng-Do (Department of Internal Medcine, Presbyterian Medical Center)
Gil, So-Hyun (Department of Internal Medcine, Presbyterian Medical Center)
Kim, Su-Jeung (Department of Radiology, Presbyterian Medical Center)
Oh, Byoung-Chul (Department of Neurology, Presbyterian Medical Center)
Kim, Ji-Hye (Department of Internal Medcine, Presbyterian Medical Center)
Publication Information
The Korean Journal of Medicine / v.79, no.2, 2010 , pp. 195-200 More about this Journal
Abstract
Moyamoya disease (MMD) is a cerebrovascular disorder characterized by bilateral stenosis or occlusion of the terminal portions of the internal carotid arteries. MMD is also accompanied by typical net-like collateral vessels in the basal ganglia. Although the etiology of MMD remains unknown, hereditary, immunogenic, and hemodynamic factors have been implicated as underlying mechanisms of MMD. Here, the authors report on one patient with a rare combination of Graves' disease-associated thyrotoxicosis, myasthenia gravis, and MMD, where cerebrovascular ischemic events occurred during a thyrotoxic state.
Keywords
Cerebral ischemia; Graves' disease; Moyamoya disease; Myasthenia gravis; Thyrotoxicosis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Inaba M, Henmi Y, Kumeda Y, Ueda M, Nagata M, Emoto M, Ishikawa T, Ishimura E, Nishixawa Y. Increased stiffness in common carotid artery in hyperthyroid Graves' disease patients. Biomed Pharmacother 56:241-246, 2002   DOI   ScienceOn
2 Kanazawa H, Eguchi K, Mine M, Ikari N, Kurata A, Fukuda T, Matsunaga M, Nagataki S. Serum from patients with autoimmune disease induces in vitro production of disease-associated antibodies by peripheral blood mononuclear cells from normal subjects. J Clin Endocrinol Metab 63:683-688, 1986   DOI
3 Utku U, Asil T, Celik Y, Tucer D. Reversible MR angiographic findings in a patient with autoimmune Graves' disease. AJNR Am J Neuroradiol 25:1541-1543, 2004
4 Colleran KM, Ratliff DM, Burge MR. Potential association of thyrotoxicosis with vitamin B and folate deficiencies, resulting in risk for hyperhomocysteinemia and subsequent thromboembolic events. Endocr Pract 9:290-295, 2003   DOI   ScienceOn
5 Sato H, Oqawa A, Fujiwara S, Sakurai Y, Kayama T, Yoshimoto T. Influence of superior cervical ganglion on cerebral hemodynamics: measurements of cerebral blood flow and metabolism during superior cervical ganglionectomy in patients with moyamoya disease. No To Shinkei 42:203-208, 1990
6 Matsumoto K, Nogaki H, Yamanoto K, Sasabe F, Morimatsu M. A case of Moyamoya disease complicated with Basedow disease. Jpn J Stroke 14:409-413, 1992   DOI
7 Suzuki J, Kodama M, Fujuwara S. A study about the cause of Moyamoya disease. The 1980 Annual Report of the Research Committee on the Idiopathic Progressive Occlusive Disease of Circle of Willis. p. 21-34, Tokyo, Japanese Ministry of Health and Welfare, 1981
8 Kim JY, Kim BS, Kang JH. Dilated cardiomyopathy in thyrotoxicosis and Moyamoya disease. Int J Cardiol 80:101-103, 2001   DOI   ScienceOn
9 Kushima K, Satoh Y, Ban Y, Taniyama M, Ito K, Sugita K. Graves' thyrotoxicosis and Moyamoya disease. Can J Neurol Sci 18:140-142, 1991
10 이형길, 오재욱, 이태규, 장대일, 정경천. Graves병과 모야모야병이 병발된 1례 보고. 대한뇌졸중학회지 2:108-111, 2000
11 Liu JS, Juo SH, Chen WH, Chang YY, Chen SS. A case of Graves' disease associated with intracranial moyamoya vessels and tubular stenosis of extracranial internal carotid arteries. J Formos Med Assoc 93:806-809, 1994
12 Tendler BE, Shoukri K, Malchoff C, MacGillivray D, Duckrow R, Talmadge T, Ramsby GR. Concorrence of Graves' disease and dysplastic cerebral blood vessels of the moyamoya variety. Thyroid 7:625-629, 1997   DOI   ScienceOn
13 Im SH, OH CW, Kwon OK, Kim JE, Han DE. Moyamoya disease associated with Graves' disease: special considerations regarding clinical significance and management. J Neurosurg 102:1013-1017, 2005   DOI   ScienceOn
14 Sasaki T, Nogawa S, Amano T. Co-morbidity of Moyamoya disease with Graves' disease: report of three case and a review of the literacture. Intern Med 45:649-653, 2006   DOI   ScienceOn
15 Erickson RP, Wooliscroft J, Allen RJ. Familial occurrence of intracranial arterial occlusive disease (Moyamoya) in neurofibromatosis. Clin Genet 18:191-196, 1980
16 Hoshimaru M, Takahashi JA, Kikuchi H, Nagata I, Hatanaka M. Possible roles of basic fibroblast growth factor in the pathogenesis of moyamoya disease: an immunohistochemical study. J Neurosurg 75:267-270, 1991   DOI
17 Yoshimoto T, Houkin K, Takahashi A, Abe H. Evaluation of cytokines in cerebrospinal fluid from patients with Moyamoya disease. Clin Neurol Neurosurg 99(Suppl 2):S218-S220, 1997
18 Suzuki J, Kowada M, Asahi M, Takaku A. A study of disease showing singular cerebral angiographic findings which seems to be new collateral circulation. Proceedings. 22nd Meeting of Japanese Neurosurggical Society, 1963
19 Siegert CE, Smelt AH, de Bruin TW. Superior sagittal sinus thrombosis and thyrotoxicosis: possible association in two cases. Stroke 26:496-497, 1995   DOI   ScienceOn
20 Simone JV, Abildgaard CF, Schulman I. Blood coagulation in thyroid dysfunction. N Engl J Med 273:1057-1061, 1965   DOI   ScienceOn